CGBIO
South Korea · Biotechnology, Health Care, Manufacturing
CGBIO is a leading biotechnology firm specializing in regenerative medicine. The company develops innovative products aimed at enhancing recovery and improving patient outcomes. With a strong focus on research and development, CGBIO works to advance medical science and technology.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- South Korea
- Employees
- 201
- Industries
- Biotechnology, Health Care, Manufacturing
- Website
- www.cgbio.co.kr
- Company page
Recent activity at CGBIO
- : CGBio Partners with Hallym Hospital to Enhance Robotic Spine Surgery Training.
- : CGBIO Forms Partnership with Sunyu Medical to Enter China's Regenerative Medicine Market. (date Fundz recorded it)
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About CGBIO: questions and answers
What does CGBIO do?
CGBIO is a leading biotechnology firm specializing in regenerative medicine. The company develops innovative products aimed at enhancing recovery and improving patient outcomes. With a strong focus on research and development, CGBIO works to advance medical science and technology.
Where is CGBIO headquartered?
CGBIO is headquartered in South Korea.
How many employees does CGBIO have?
CGBIO has about 201 employees.
What is the latest news on CGBIO?
On Nov 9, 2026, CGBio Partners with Hallym Hospital to Enhance Robotic Spine Surgery Training.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy